Khleif Samir N., Rixe Olivier, Skeel Roland T. (eds.) Skeel's Handbook of Cancer Therapy

9th edition. — Wolters Kluwer, 2016. — 954 p. — ISBN: 9781496305558For more than 30 years, Skeel’s Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy ) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including innovations in immunotherapy, oncology genomics, and molecular targeted therapy. An invaluable reference for all levels of physicians, nurses, and allied health professionals who provide care to cancer patients, this bestselling guide combines the most current rationale and the details necessary to safely administer pharmacologic therapy, offering a balanced synthesis between science and clinical practice.Basic principles and considerations of rational chemotherapy and molecular targeted therapy
Biologic basis of molecular targeted therapy
Principles of cancer immunotherapy
Systematic assessment of the patient with cancer and consequences of treatment
Selection of treatment for the patient with cancer
Medical therapies of human cancer
Carcinomas of the head and neck
Carcinoma of the lung
Carcinomas of the gastrointestinal tract
Carcinomas of the pancreas, liver, gallbladder, and bile ducts
Carcinoma of the breast
Gynecologic cancer
Urologic and male genital cancers
Kidney cancer
Endocrine cancers
Melanomas and other cutaneous malignancies
Primary and metastatic brain tumors
Soft-tissue sarcomas
Bone sarcomas
Acute leukemias
Chronic leukemias
Myeloproliferative neoplasms and myelodysplastic syndromes
Hodgkin lymphoma
Non-Hodgkin lymphoma
Multiple myeloma, other plasma cell disorders, and primary amyloidosis
Metastatic cancer of unknown origin
]Supportive care of patients with cancer
Side effects of chemotherapy
Side effects of immune therapy
Chemotherapeutic and molecular targeted agents and their use
Classification, use, and toxicity of clinically useful chemotherapy and molecular targeted therapy